CD274 and neoplasm: Increased PD-L1 expression following treatment with DDR inhibitors is mainly IRF3-dependent [25], and tumor-growth inhibition and immune-checkpoint blockade with DDR inhibitors is completely dependent on the cGAS–STING–IRF3 axis.